Certain Philips Respironics DreamStation breathing devices, commonly used for treating sleep apnea, may deliver the incorrect prescription or no therapy at all, the FDA warned in a recall announcement ...
On April 7, 2023, the FDA identified a Class I recall on the Philips Respironics CPAP and BiPAP machines due to inaccurate or insufficient therapy. The devices, intended for treating sleep apnea, had ...
The U.S. Food and Drug Administration on Friday announced the recall of certain Philips Respironics devices designed to help people with breathing conditions keep breathing at a regular rhythm. The ...
Drugwatch has provided people injured by harmful drugs and devices with reliable answers and experienced legal help since 2009. Brought to you by The Wilson Firm LLP, we've pursued justice for more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results